Accomplished drug discovery team developing meaningful oral therapies for patients with immune-mediated and chronic diseases
Location: United States
Total raised: $50M
Investors 1
| Date | Name | Website |
| 13.07.2025 | Foresite C... | foresiteca... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.08.2026 | Series B | $50M | - |
Mentions in press and media 6
| Date | Title | Description |
| 13.08.2026 | Khartis Therapeutics Raises $50M To Advance Oral Immunology Drugs | Khartis Therapeutics Raises $50M Series B Khartis Therapeutics has raised $50 million in Series B funding to advance its oral medicine pipeline.mForge Life Science Partners led the round. Longwood Fund and Alexandria Venture Investments joi... |
| 13.08.2026 | Thrive Holdings Raises $2B To Expand AI-Powered Business Roll-Ups | Thrive Holdings Raises $2B At $12B Valuation Thrive Holdings has raised $2 billion in new funding at a $12 billion valuation. SoftBank, D1 Capital Partners and Altimeter Capital led the financing. The round marks the first external investme... |
| 13.08.2026 | Venture Capital & Startup Funding Roundup, August 13, 2026: Blackstone, Coatue, Founders Fund, Sequoia Capital, Thiel Capital & More | Venture dollars are again clustering around AI and infrastructure. Today’s biggest deal saw Databricks haul in a record-breaking $5 billion at a $190 billion valuation. That massive raise – led by Coatue, Blackstone, MGX, T. Rowe Price, and... |
| 13.08.2026 | Khartis Therapeutics Raises $50M in Series B Funding | Khartis Therapeutics, a San Diego, CA-based provider of a biotechnology platform developing therapies for immunological and chronic diseases, raised $50M in Series B funding. The round was led by Forge Life Science Partners with participati... |
| 13.08.2026 | Khartis Therapeutics Raises $50 Million Series B, Bringing Total Funding To $95 Million | Khartis Therapeutics has raised $50 million in Series B funding to advance its pipeline of oral small molecule therapies targeting immunological and chronic diseases, bringing total capital raised to $95 million. Forge Life Science Partners... |
| - | Khartis Therapeutics | “Accomplished drug discovery team developing meaningful oral therapies for patients with immune-mediated and chronic diseases” |